These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 10851729

  • 1. [P185 (Neu) oncoprotein in the prognosis of bladder carcinoma. Experience of 5 years].
    Moreno Sierra J, Maestro de las Casas ML, Redondo González E, Fernández Pérez C, del Barco Barriuso V, Sanz Casla MT, Blanco Jiménez E, Silmi Moyano A, Resel Estévez L.
    Arch Esp Urol; 2000 Apr; 53(3):238-44. PubMed ID: 10851729
    [Abstract] [Full Text] [Related]

  • 2. [Quantification of p53 oncoprotein in bladder carcinoma: 5-year experience].
    Moreno Sierra J, Maestro de las Casas ML, Fernández Pérez C, Redondo González E, Sanz Casla MT, del Barco Barriuso V, Blanco Jiménez E, Silmi Moyano A, Resel Estévez L.
    Arch Esp Urol; 1999 Apr; 52(3):220-7. PubMed ID: 10371737
    [Abstract] [Full Text] [Related]

  • 3. [Usefulness of p53 oncoprotein immunohistochemistry in the follow-up of bladder carcinoma: a 5-year study].
    Moreno Sierra J, López García Asenjo JA, Redondo González E, Fernández Pérez C, Maestro de las Casas ML, Blanco Jiménez E, Silmi Moyano A, Resel Estévez L.
    Arch Esp Urol; 1999 Oct; 52(8):840-8. PubMed ID: 10589115
    [Abstract] [Full Text] [Related]

  • 4. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB, Zeng FH, Sun ZQ.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038
    [Abstract] [Full Text] [Related]

  • 6. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.
    Oncol Rep; 2006 Aug 05; 16(2):329-34. PubMed ID: 16820911
    [Abstract] [Full Text] [Related]

  • 7. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R, Lara PN, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R.
    Cancer; 2002 Sep 01; 95(5):1009-15. PubMed ID: 12209684
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
    Jalali Nadoushan MR, Taheri T, Jouian N, Zaeri F.
    Urol J; 2007 Sep 01; 4(3):151-4. PubMed ID: 17987577
    [Abstract] [Full Text] [Related]

  • 9. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Sep 01; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
    Krüger S, Weitsch G, Büttner H, Matthiensen A, Böhmer T, Marquardt T, Sayk F, Feller AC, Böhle A.
    Int J Oncol; 2002 Nov 01; 21(5):981-7. PubMed ID: 12370744
    [Abstract] [Full Text] [Related]

  • 11. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E.
    Aktuelle Urol; 2005 Sep 01; 36(5):423-9. PubMed ID: 16163605
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors].
    Ramos Soler D, Navarro Fos S, Villamón Fort R, Gil Salom M, Llombart Bosch A.
    Arch Esp Urol; 2003 Apr 01; 56(3):277-85. PubMed ID: 12768988
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M, Bartoletti R.
    Oncol Rep; 2006 Jan 01; 15(1):213-9. PubMed ID: 16328058
    [Abstract] [Full Text] [Related]

  • 14. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 01; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 15. Cox-2 and Her2/neu co-expression in invasive bladder cancer.
    Eltze E, Wülfing C, Von Struensee D, Piechota H, Buerger H, Hertle L.
    Int J Oncol; 2005 Jun 01; 26(6):1525-31. PubMed ID: 15870865
    [Abstract] [Full Text] [Related]

  • 16. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE.
    Cancer; 2009 Feb 15; 115(4):770-5. PubMed ID: 19152431
    [Abstract] [Full Text] [Related]

  • 17. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.
    Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y, Matsubara H, Yamamoto K, Nan Li Y, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T.
    Cancer; 2004 Oct 15; 101(8):1794-802. PubMed ID: 15386310
    [Abstract] [Full Text] [Related]

  • 19. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.
    Salinas-Sánchez AS, Lorenzo-Romero JG, Giménez-Bachs JM, Sánchez-Sánchez F, Donate-Moreno MJ, Rubio-Del-Campo A, Hernández-Millán IR, Segura-Martín M, Atienzar-Tobarra M, Escribano-Martínez J.
    Urol Oncol; 2008 Oct 15; 26(6):620-6. PubMed ID: 18367096
    [Abstract] [Full Text] [Related]

  • 20. HER2/neu expression in bladder cancer: relationship to cell cycle kinetics.
    Eissa S, Ali HS, Al Tonsi AH, Zaglol A, El Ahmady O.
    Clin Biochem; 2005 Feb 15; 38(2):142-8. PubMed ID: 15642276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.